Brief: Cytomed Therapeutics Limited Announces Collaboration With MD Anderson Cancer Center To Advance Allogeneic Off-The-Shelf Gamma Delta T Cells In Oncology
09/05/2023 15:31
May 9 (Reuters) - CytoMed Therapeutics Ltd GDTC.O :
* CYTOMED THERAPEUTICS LIMITED ANNOUNCES COLLABORATION WITH
MD
ANDERSON CANCER CENTER TO ADVANCE ALLOGENEIC OFF-THE-SHELF GAMMA
DELTA T CELLS IN ONCOLOGY
Source text for Eikon: ID:nPnsqRRBa
Further company coverage: GDTC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CytoMed Therapeutics
See all newsBrief: Cytomed Therapeutics Limited Announces Receipt Of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Brief: Cytomed Therapeutics Refutes "Misleading" Claims & Reaffirms Clinical Progress
Brief: Cytomed Therapeutics Completes Acquisition Of T Cell Technology From Uk To Treat Cancers In China And India
Brief: CytoMed Therapeutics To Start Dose Level 2 In Angelica Trial Q3 2025
Brief: Cytomed Therapeutics Ltd Files For Mixed Shelf Of Up To $50 Million